Impaired Binding to Junctophilin-2 and Nanostructural Alteration in CPVT Mutation

Archive ouverte

Yin, Liheng | Zahradnikova, Alexandra | Rizzetto, Riccardo | Boncompagni, Simona | Rabesahala de Meritens, Camille | Zhang, Yadan | Joanne, Pierre | Marqués-Sulé, Elena | Aguilar- Sánchez, Yuriana | Fernández-Tenorio, Miguel | Villejoubert, Olivier | Li, Linwei | Wang, Yue, Yi | Mateo, Philippe | Nicolas, Valérie | Gerbaud, Pascale | Lai, F. Anthony, Anthony | Perrier, Romain | Álvarez, Julio, L | Niggli, Ernst | Valdivia, Héctor, H | Valdivia, Carmen, R | Ramos-Franco, Josefina | Zorio, Esther | Zissimopoulos, Spyros | Protasi, Feliciano | Benitah, Jean-Pierre | Gómez, Ana, M

Edité par CCSD ; American Heart Association -

International audience. Rationale:Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare disease, manifested by syncope or sudden death in children or young adults under stress conditions. Mutations in the Ca2+ release channel/RyR2 (type 2 ryanodine receptor) gene account for about 60% of the identified mutations. Recently, we found and described a mutation in RyR2 N-terminal domain, RyR2R420Q.Objective:To determine the arrhythmogenic mechanisms of this mutation.Methods and Results:Ventricular tachycardias under stress conditions were observed in both patients with catecholaminergic polymorphic ventricular tachycardia and knock-in mice. During action potential recording (by patch-clamp in knock-in mouse cardiomyocytes and by microelectrodes in mutant human induced pluripotent stem cell-derived cardiomyocytes), we observed an increased occurrence of delayed afterdepolarizations under isoproterenol stimulation, associated with increased Ca2+ waves during confocal Ca2+ recording in both mouse and human RyR2R420Q cardiomyocytes. In addition, Ca2+-induced Ca2+-release, as well as a rough indicator of fractional Ca2+ release, were higher and Ca2+ sparks longer in the RyR2R420Q-expressing cells. At the ultrastructural nanodomain level, we observed smaller RyR2 clusters and widened junctional sarcoplasmic reticulum measured by gated stimulated emission depletion super-resolution and electron microscopy, respectively. The increase in junctional sarcoplasmic reticulum width might be due to the impairment of RyR2R420Q binding to JPH2 (junctophilin-2), as there were less junctophilin-2 coimmunoprecipitated with RyR2R420Q. At the single current level, the RyR2R420Q channel dwells longer in the open state at low intracellular Ca2+ ([Ca2+]i), but there is predominance of a subconductance state. The latter might be correlated with an enhanced interaction between the N terminus and the core solenoid, a RyR2 interdomain association that has not been previously implicated in the pathogenesis of arrhythmias and sudden cardiac death.Conclusions:The RyR2R420Q catecholaminergic polymorphic ventricular tachycardia mutation modifies the interdomain interaction of the channel and weakens its association with JPH2. These defects may underlie both nanoscale disarrangement of the dyad and channel dysfunction.

Suggestions

Du même auteur

RyR2R420Q catecholaminergic polymorphic ventricular tachycardia mutation induces bradycardia by disturbing the coupled clock pacemaker mechanism

Archive ouverte | Wang, Yue Yi | CCSD

International audience. Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a lethal genetic arrhythmia that manifests syncope or sudden death in children and young adults under stress conditions. CPVT p...

Mineralocorticoid modulation of cardiac ryanodine receptor activity is associated with downregulation of FK506-binding proteins.

Archive ouverte | Gómez, Ana María | CCSD

International audience. BACKGROUND: The mineralocorticoid pathway is involved in cardiac arrhythmias associated with heart failure through mechanisms that are incompletely understood. Defective regulation of the car...

Progression of excitation-contraction coupling defects in doxorubicin cardiotoxicity

Archive ouverte | Llach, Anna | CCSD

International audience. Cardiac failure is a common complication in cancer survivors treated with anthracyclines. Here we followed up cardiac function and excitation-contraction (EC) coupling in an in vivo doxorubic...

Chargement des enrichissements...